Frontline: Breast Cancer Drug Trial; Muscle-Strengthening Exercise; Chronic Inflammation & Alzheimer’s Disease

Drug Extends Survival Time for Breast Cancer Patients An international clinical trial called PALOMA-3 evaluated the medication palbociclib in 521 women with hormone receptor-positive metastatic breast cancer whose cancer had relapsed or progressed following treatment with hormone therapy. Palbociclib (brand name Ibrance) is a novel oral drug that inhibits enzymes that are needed for cell […]

Comments

Leave a Reply

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×